?? Calling all retina specialists and eyecare professionals! Test your #ophthalmology expertise with our #ApellisEyeQ poll!
此处无法显示此内容
在领英 APP 中访问此内容等
Apellis Pharmaceuticals
生物技术研究
Waltham，MA 78,949 位关注者
Global biopharma company leveraging courageous science, creativity, and compassion to deliver life-changing therapies.
关于我们
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system. Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available. Our programs across ophthalmology, nephrology, hematology, and neurology are further exploring what is possible by targeting C3. You can view our community guidelines here: Community guidelines: https://bit.ly/476Q8
- 网站
-
https://apellis.com/
Apellis Pharmaceuticals的外部链接
- 所属行业
- 生物技术研究
- 规模
- 501-1,000 人
- 总部
- Waltham，MA
- 类型
- 上市公司
- 创立
- 2008
- 领域
- Targeted C3 Therapies、Complement System、Hematology、Ophthalmology、Nephrology、Paroxysmal Nocturnal Hemoglobinuria (PNH)、Geographic Atrophy (GA)、C3 Glomerulopathy (C3G)、Cold Agglutinin Disease (CAD)、Gene Therapy、Neurology和Amyotrophic Lateral Sclerosis (ALS)
地点
Apellis Pharmaceuticals员工
动态
-
Today is #WorldKidneyDay - a moment to raise awareness about kidney diseases, including rare conditions like C3G and IC-MPGN. Hear from Christina, who is currently living with C3G, about what she wishes others knew about living with a kidney disease. #WeAreApellis
-
-
Apellis is made up of people who are passionate about our work, our purpose, and the positive impact we can make for our patients. On #EmployeeAppreciationDay we’re celebrating YOU – our fearless Apellucians! Thank you for all you do. ?? #WeAreApellis
-
-
At Apellis, we know that cultivating a diverse and inclusive workforce takes intention. We’re proud to support #InternationalWomensDay this Saturday and celebrate the women who make a difference every day—within our company, across our industry, and around the world. #WeAreApellis #WeBelong #IWD2025 #AccelerateAction
-
We’re proud to support our partners Aplastic Anemia & MDS International Foundation as they raise awareness of rare blood diseases like PNH this week. Hear from Ashley, who is currently living with PNH, about her tips for managing the condition, or visit https://lnkd.in/eDFeDqmk to access helpful resources for patients and caregivers. #WeAreApellis?
-
Today, we are proud to share our Q4 2024 financial results and highlights. $APLS https://bit.ly/4khL11L
-
-
Tomorrow is #RareDiseaseDay! Join us and #ShowYourStripes to raise awareness and support for the rare disease community. Check out the resources from the National Organization for Rare Disorders to learn more: https://bit.ly/3EU2mhd #WeAreApellis #RDD2025
-
This year’s #BlackHistoryMonth theme, "African Americans and Labor," recognizes the invaluable contributions of Black individuals across all fields, including the scientific pioneers whose intellectual labor has shaped the world we live in today. At Apellis, we’ve spent this month learning more about Black innovators in STEM – from ophthalmology to space exploration. Our #WeBelong value reminds us that we are at our best when we overcome obstacles together—by embracing diverse perspectives, lived experiences, and fearless collaboration. Join us in learning more about these scientific pioneers below! #WeAreApellis
-
-
Today, we announced with our partners at Sobi that the European Medicines Agency (EMA) validated an indication extension application of our investigational treatment for C3G and IC-MPGN, rare kidney diseases with no approved treatment options. Learn more: https://bit.ly/417kITl
-
-
One of humankind’s greatest fears is permanent vision loss. That’s why we are fearless in the fight against vision loss and committed to moving the field forward. During #AMDAwarenessMonth, learn more about #GeographicAtrophy (GA), an advanced form of #AMD that leads to progressive and irreversible vision loss: https://bit.ly/3QlKtKH #WeAreApellis